Suchergebnisse - "Angiotensin II Type 1 Receptor Blockers"

PubPharm (9.314)

81

Impact of renin-angiotensin-aldosterone system inhibitors on COVID-19

enthalten in: Hypertension research : official journal of the Japanese Society of Hypertension | 2022

von Matsuzawa, Y. | Kimura, K. | Ogawa, H. | +1

82

A Giant Left Coronary Button Aneurysm After Aortic Root Remodeling Procedure in a Patient With Marfan Syndrome : A Case Report

enthalten in: Cureus | 2022

von Higashino, A. | Taketani, T. | Suzuki, H. | +2

83

Fimasartan Ameliorates Deteriorations in Glucose Metabolism in a High Glucose State by Regulating Skeletal Muscle and Liver Cells

enthalten in: Yonsei medical journal | 2022

von Jang, Y. | Lee, Y. | Han, Y. | +5

84

Pleiotropic activation of endothelial function by angiotensin II receptor blockers is crucial to their protective anti-vascular remodeling effects

enthalten in: Scientific reports | 2022

von Tehrani, A. | White, Z. | Tung, L. | +9

85

Renin-Angiotensin Aldosterone System Inhibitors and COVID-19 : A Systematic Review and Meta-Analysis Revealing Critical Bias Across a Body of Observational Research

enthalten in: Journal of the American Heart Association | 2022

von Loader, J. | Taylor, F. | Lampa, E. | +1

86

Cardiovascular therapeutics : A new potential for anxiety treatment?

enthalten in: Medicinal research reviews | 2022

von Repova, K. | Aziriova, S. | Krajcirovicova, K. | +1

87

Efficacy and safety of sacubitril/valsartan in the treatment of middle-aged and elderly patients with hypertension : a systematic review and meta-analysis of randomized controlled trials

enthalten in: Annals of palliative medicine | 2022

von Wu, H. | Liu, K. | Li, B. | +2

88

Telmisartan is the most effective ARB to increase adiponectin via PPARα in adipocytes

enthalten in: Journal of molecular endocrinology | 2022

von Hattori, N. | Yamada, A. | Nakatsuji, S. | +3

89

Effects of losartan on bladder dysfunction due to aging-related severe hypertension in rats

enthalten in: European journal of pharmacology | 2022

von Shimizu, S. | Nagao, Y. | Kurabayashi, A. | +4

90

Effects of α lipoic acid combined with olmesartan medoxomil on blood glucose and oxidation indicators in patients with diabetic nephropathy : A protocol for a parallel, randomized, double-blind, controlled clinical trial

enthalten in: Medicine | 2022

von Jiao, S. | Dong, Y. | Chang, X. | +2